黑料官网

header-logo
GettyImages-145652391-hero
Surgery
Christian Kastrup, PhD

Christian Kastrup, PhD

Professor, Department of Surgery; Senior Investigator, Versiti Blood Research Institute; Secondary Faculty

Locations

  • BRI 2010

Contact Information

Publications

  • (Chowdhury NN, Mitchell DK, Kangro K, Eldridge K, Abrahams S, Ferraresso F, Juang LJ, Gampala S, Brewster K, Revenko A, Kastrup C, Territo PR, Clapp DW, Wang J, Belgodere JA, Saeed O, Choi SR, Han B, Wolberg AS, Cao S, Zhang C, Flick MJ, Fishel ML.) Gastroenterology. 2026 Apr;170(4):753-768 PMID: 41432649 PMCID: PMC12731649 12/23/2025

  • (Lee RH, Ferraresso F, Couzens A, Jameson AT, Hanes HE, Casini A, Neerman-Arbez M, Nieswandt B, Kastrup CJ, Bergmeier W, Flick MJ, Hur WS.) Blood. 2026 Mar 05 PMID: 41790575 03/06/2026

  • (Seadler MS, Ferraresso F, Turner HM, Ketelboeter LM, Zhang Y, Badior K, Hayssen WG, Chen T, Haugen AL, Cau MF, Robertson M, Skaer C, Bansal M, Murphy PB, de Moya M, Dyer MR, Kastrup CJ.) J Thromb Haemost. 2026 Feb;24(2):508-519 PMID: 41076269 PMCID: PMC12766900 SCOPUS ID: 2-s2.0-105024948193 10/12/2025

  • (Ferraresso F, Skaer CW, Wei Z, Paul M, Hur WS, Yu H, Seadler M, Chen THY, Dai W, Lapointe C, Ketelboeter LM, Lund H, Rodriguez GG, Juang LJ, Strilchuk AW, Zhang Y, Cullis PR, Dyer MR, Gerras AL, Shi Q, Luyendyk JP, Flick MJ, Kastrup CJ.) Blood. 2026 Jan 26 PMID: 41587091 PMCID: PMC12994142 SCOPUS ID: 2-s2.0-105034593821 01/26/2026

  • (Peng HT, Kastrup CJ, Tenn C, Beckett A.) Front Drug Deliv. 2026;6:1771095 PMID: 41799410 PMCID: PMC12960590 03/09/2026

  • (Ali-Mohamad N, Wang TH, Juang LJ, Peng N, Cau MF, Cannon K, Kastrup CJ.) Res Pract Thromb Haemost. 2026 Jan;10(1):103342 PMID: 41676354 PMCID: PMC12887395 02/12/2026

  • (Singh V, Rochakim N, Ferraresso F, Garg K, Rizvi AB, Choudhury A, Kastrup CJ, Ahn HJ.) Alzheimers Dement. 2026 Jan;22(1):e71030 PMID: 41549419 PMCID: PMC12812864 01/19/2026

  • (Ferraresso F, Skaer CW, Badior K, Pulente SM, Paul M, Ketelboeter L, Chen THS, Cullis PR, Gupta S, Shapiro A, Mulvihill EE, Kastrup CJ.) Mol Ther Methods Clin Dev. 2025 Sep 11;33(3):101557 PMID: 40917690 PMCID: PMC12410550 09/08/2025

  • (Peng HT, Bonnici T, Kastrup C, Beckett A.) Mil Med. 2025 Sep 01;190(Supplement_2):662-669 PMID: 40984119 09/23/2025

  • (Ali-Mohamad N, Singh K, Cau MF, Tenn C, Bince D, Kamide C, Peng H, Semple H, Kastrup CJ, Beckett A.) Mil Med. 2025 Sep 01;190(9-10):e1929-e1936 PMID: 40156908 03/30/2025

  • (Shifman SG, O'Connor JL, Radin DP, Sharma A, Infante L, Ferraresso F, Kastrup CJ, Lawrence DA, Tsirka SE.) J Exp Clin Cancer Res. 2025 Jul 19;44(1):214 PMID: 40684232 PMCID: PMC12275254 07/20/2025

  • (Peng HT, Bonnici T, Chen Y, Kastrup C, Beckett A.) J Funct Biomater. 2025 Mar 03;16(3) PMID: 40137365 PMCID: PMC11942888 03/26/2025

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.